How much does Nuplazid cost without insurance?
In 2023, the average retail price of Nuplazid (pimavanserin) in the United States is around $850-$1,200 per 34mg tablet [1]. However, prices may vary depending on your location, pharmacy, and insurance coverage. Prices can also fluctuate over time as wholesalers, pharmacies, and manufacturers negotiate contracts.
Is Nuplazid expensive?
Yes, Nuplazid is considered a costly medication. Without insurance, patients may need to pay the full list price, which can be unaffordable for many individuals. Even with insurance, patients may still face high out-of-pocket costs due to copayments, coinsurance, or deductible requirements.
How do out-of-pocket costs work for Nuplazid?
Out-of-pocket costs depend on your insurance plan, copayment, coinsurance, and deductible. Typically, the patient pays a flat copayment (e.g., $50) or a percentage of the total cost (coinsurance, e.g., 20%) after reaching their deductible. For example, if the copayment is $50 per tablet and you take one tablet per month, your out-of-pocket cost would be $600 for a 30-day supply.
Alternatives to Nuplazid
There are no exact Nuplazid alternatives due to its unique mechanism of action, but there are other medications used to treat similar symptoms in Parkinson's disease psychosis, such as aripiprazole (Abilify) [2]. These medications may have different prices, but they can be worth considering for patients who cannot afford Nuplazid.
Clinical trials and off-label use
Pharmaceutical companies like Acadia Pharmaceuticals, which manufactures Nuplazid, sponsor clinical trials and promote off-label use for their medications. These initiatives can provide more treatment options for patients but may also increase costs [3].
Pricing and patent information
As a result of its patent protection, the Nuplazid patent expires on a specific date in the future. This can lead to generic versions becoming available, which may lower the medication's costs. For more information, see DrugPatentWatch.com [4].
Sources:
[1] https://www.goodrx.com/pimavanserin
[2] https://www.drugs.com/aripiprazole.html
[3] https://www.clinicaltrials.gov/
[4] https://drugpatentwatch.com/patents/US10241951